CD163 and portal hypertension: A gradient across the liver has been demonstrated suggesting intrahepatic secretion [95]; and the sCD163 concentration correlates with the degree of portal hypertension, and represents a clinically relevant non-invasive and cost-effective tool to detect clinically significant portal hypertension in cirrhosis patients [92,95].